http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-082932-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bceb71676971f1383ae2a7e5ccaa7da
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a805ad098c57c4b1627d5fbc3f5ae4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_308f54c9f03603c88c4262f87ad31639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031a01bf85fe70d0d1f3c8880ab5a7d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4767424205493821ac145d89d7fc6908
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e4bf539ee8a81827053a40a050ca676
publicationDate 2013-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-082932-A1
titleOfInvention INDAZOL DERIVATIVES AS MODULATORS OF THE RECEPTOR OF STROGENS AND USES OF THE SAME
abstract Compounds that are estrogen receptor modulators are described herein. Pharmaceutical compositions and medicaments including the compounds described herein, as well as methods for using such estrogen receptor modulators, alone or in combination with other compounds, for treating diseases or conditions that are mediated or dependent on estrogen receptors are also described. Claim 1: A compound of the formula (1), or a pharmaceutically acceptable salt thereof, or an N-oxide thereof, where Z is -OH or -OR10; R2 is C1-4 alkyl, C1-4 fluoroalkyl, deutero-C1-4 alkyl, C3-6 cycloalkyl, or C1-4-W alkylene; W is hydroxy, halogen, CN, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, or C3-6 cycloalkyl; each R3 is independently halogen, C1-4 alkyl, or C1-4 fluoroalkyl; each R4 is independently halogen, -CN, -OR9, -S (= O) 2R10, C1-4 alkyl, C1-4 fluoroalkyl, or C1-4 heteroalkyl; each R5 is independently halogen, -CN, -OR9, -S (= O) 2R10, C1-4 alkyl, C1-4 fluoroalkyl, or C1-4 heteroalkyl; R6 is H, C1-4 alkyl, or halogen; R7 is H, C1-4 alkyl, or halogen; R9 is H, C1-6 alkyl, C1-6 fluoroalkyl, or C3-6 cycloalkyl; R10 is C1-6 alkyl; m is 0, 1 or 2; n is 0, 1, 2, 3 or 4; and p is 0, 1 or 2.
priorityDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407608385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9221

Total number of triples: 19.